Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
2651
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.77M | ﹤0.01% |
226,439
+3,641
| +2% | +$30.5K |
|
|
NVRO
2652
DELISTED
NEVRO CORP.
NVRO
| $1.76M | ﹤0.01% |
301,645
-12,836
| -4% | -$67.6K |
|
2653
Frontline
FRO
$8.81B
| $1.76M | ﹤0.01% |
118,566
+46,594
| +65% | +$770K |
|
2654
Beyond Meat
BYND
$272M
| $1.75M | ﹤0.01% |
573,596
+46,540
| +9% | +$171K |
|
2655
Absci
ABSI
$1.41B
| $1.75M | ﹤0.01% |
695,895
-33,154
| -5% | -$122K |
|
2656
Entrada Therapeutics
TRDA
$267M
| $1.74M | ﹤0.01% |
192,717
-4,410
| -2% | -$55K |
|
2657
Global Ship Lease
GSL
$1.54B
| $1.73M | ﹤0.01% |
75,644
+58,872
| +351% | +$1.32M |
|
2658
Energy Fuels
UUUU
$3.22B
| $1.71M | ﹤0.01% |
459,326
+7,817
| +2% | +$37.5K |
|
2659
FLEX LNG
FLNG
$1.68B
| $1.71M | ﹤0.01% |
74,519
+1,234
| +2% | +$29.5K |
|
2660
ATN International
ATNI
$471M
| $1.71M | ﹤0.01% |
84,136
-18,327
| -18% | -$329K |
|
|
INGM
2661
Ingram Micro Holding
INGM
$6.59B
| $1.71M | ﹤0.01% |
+96,144
| New | +$2.05M |
|
2662
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.7M | ﹤0.01% |
30,344
-4
| -0% | -$238 |
|
|
CIO
2663
DELISTED
City Office REIT
CIO
| $1.69M | ﹤0.01% |
325,665
-7,944
| -2% | -$40.8K |
|
2664
Allogene Therapeutics
ALLO
$680M
| $1.69M | ﹤0.01% |
1,155,844
-32,994
| -3% | -$62.2K |
|
2665
Porch Group
PRCH
$1.75B
| $1.69M | ﹤0.01% |
231,158
-17,042
| -7% | -$92.4K |
|
|
ILPT
2666
Industrial Logistics Properties Trust
ILPT
$575M
| $1.68M | ﹤0.01% |
489,748
-473,522
| -49% | -$1.77M |
|
|
ATXS
2667
DELISTED
Astria Therapeutics
ATXS
| $1.68M | ﹤0.01% |
315,016
-7,560
| -2% | -$52.9K |
|
|
AEVA
2668
Aeva Technologies
AEVA
$1.73B
| $1.68M | ﹤0.01% |
239,823
-2,553
| -1% | -$10.5K |
|
2669
Tredegar Corp
TG
$270M
| $1.68M | ﹤0.01% |
217,954
+142,822
| +190% | +$1.1M |
|
2670
Monte Rosa Therapeutics
GLUE
$1.33B
| $1.68M | ﹤0.01% |
361,535
-8,937
| -2% | -$54.8K |
|
|
MOFG
2671
DELISTED
MidWestOne Financial Group
MOFG
| $1.66M | ﹤0.01% |
56,195
-792
| -1% | -$23.9K |
|
|
JKS
2672
JinkoSolar
JKS
$847M
| $1.66M | ﹤0.01% |
+89,062
| New | +$1.98M |
|
2673
GCM Grosvenor
GCMG
$814M
| $1.66M | ﹤0.01% |
125,388
+2,276
| +2% | +$30.4K |
|
2674
Aehr Test Systems
AEHR
$3.25B
| $1.65M | ﹤0.01% |
225,923
+10,327
| +5% | +$114K |
|
2675
EverCommerce
EVCM
$1.88B
| $1.64M | ﹤0.01% |
162,862
-5,725
| -3% | -$58.3K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.